107 related articles for article (PubMed ID: 31934032)
21. MZF-1/Elk-1 Complex Binds to Protein Kinase Cα Promoter and Is Involved in Hepatocellular Carcinoma.
Yue CH; Huang CY; Tsai JH; Hsu CW; Hsieh YH; Lin H; Liu JY
PLoS One; 2015; 10(5):e0127420. PubMed ID: 26010542
[TBL] [Abstract][Full Text] [Related]
22. The myeloid zinc finger gene (MZF-1) delays retinoic acid-induced apoptosis and differentiation in myeloid leukemia cells.
Robertson KA; Hill DP; Kelley MR; Tritt R; Crum B; Van Epps S; Srour E; Rice S; Hromas R
Leukemia; 1998 May; 12(5):690-8. PubMed ID: 9593266
[TBL] [Abstract][Full Text] [Related]
23. A SWI2/SNF2-type ATPase/helicase protein, mDomino, interacts with myeloid zinc finger protein 2A (MZF-2A) to regulate its transcriptional activity.
Ogawa H; Ueda T; Aoyama T; Aronheim A; Nagata S; Fukunaga R
Genes Cells; 2003 Apr; 8(4):325-39. PubMed ID: 12653961
[TBL] [Abstract][Full Text] [Related]
24. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
25. Neisseria gonorrhoeae MlaA influences gonococcal virulence and membrane vesicle production.
Baarda BI; Zielke RA; Le Van A; Jerse AE; Sikora AE
PLoS Pathog; 2019 Mar; 15(3):e1007385. PubMed ID: 30845186
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
27. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
Jenal M; Trinh E; Britschgi C; Britschgi A; Roh V; Vorburger SA; Tobler A; Leprince D; Fey MF; Helin K; Tschan MP
Mol Cancer Res; 2009 Jun; 7(6):916-22. PubMed ID: 19491197
[TBL] [Abstract][Full Text] [Related]
28. An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation.
Ferguson P; Hills RK; Grech A; Betteridge S; Kjeldsen L; Dennis M; Vyas P; Goldstone AH; Milligan D; Clark RE; Russell NH; Craddock C;
Haematologica; 2016 Nov; 101(11):1351-1358. PubMed ID: 27540133
[TBL] [Abstract][Full Text] [Related]
29. miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells.
Zauli G; Voltan R; di Iasio MG; Bosco R; Melloni E; Sana ME; Secchiero P
Clin Cancer Res; 2011 May; 17(9):2712-24. PubMed ID: 21367750
[TBL] [Abstract][Full Text] [Related]
30. E2F1 and TFDP1 Regulate PITX1 Expression in Normal and Osteoarthritic Articular Chondrocytes.
Pellicelli M; Picard C; Wang D; Lavigne P; Moreau A
PLoS One; 2016; 11(11):e0165951. PubMed ID: 27802335
[TBL] [Abstract][Full Text] [Related]
31. Myeloid zinc-finger 1 (MZF-1) suppresses prostate tumor growth through enforcing ferroportin-conducted iron egress.
Chen Y; Zhang Z; Yang K; Du J; Xu Y; Liu S
Oncogene; 2015 Jul; 34(29):3839-47. PubMed ID: 25284586
[TBL] [Abstract][Full Text] [Related]
32. High expression of lnc-CRNDE presents as a biomarker for acute myeloid leukemia and promotes the malignant progression in acute myeloid leukemia cell line U937.
Wang Y; Zhou Q; Ma JJ
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):763-770. PubMed ID: 29461608
[TBL] [Abstract][Full Text] [Related]
33. Regulation of the human mitotic centromere-associated kinesin (MCAK) promoter by the transcription factors Sp1 and E2F1.
Jun DY; Park HS; Lee JY; Kim YH
Biochim Biophys Acta; 2008 May; 1779(5):356-61. PubMed ID: 18440323
[TBL] [Abstract][Full Text] [Related]
34. Transcription factor E2F1 is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene.
Schayek H; Bentov I; Rotem I; Pasmanik-Chor M; Ginsberg D; Plymate SR; Werner H
Growth Horm IGF Res; 2010 Feb; 20(1):68-72. PubMed ID: 19703789
[TBL] [Abstract][Full Text] [Related]
35. Myeloid cell differentiation in response to calcitriol for expression CD11b and CD14 is regulated by myeloid zinc finger-1 protein downstream of phosphatidylinositol 3-kinase.
Moeenrezakhanlou A; Shephard L; Lam L; Reiner NE
J Leukoc Biol; 2008 Aug; 84(2):519-28. PubMed ID: 18495781
[TBL] [Abstract][Full Text] [Related]
36. Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy.
Sander FE; Nilsson M; Rydström A; Aurelius J; Riise RE; Movitz C; Bernson E; Kiffin R; Ståhlberg A; Brune M; Foà R; Hellstrand K; Thorén FB; Martner A
Cancer Immunol Immunother; 2017 Nov; 66(11):1473-1484. PubMed ID: 28721449
[TBL] [Abstract][Full Text] [Related]
37. [Expression of E2F1 Gene in Acute Leukemia and Its Clinical Significance].
Zhuang XL; Guan RT; Wu SX; Miu D; Qin T
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):311-316. PubMed ID: 29665891
[TBL] [Abstract][Full Text] [Related]
38. Promoter occupancy of MLL1 histone methyltransferase seems to specify the proliferative and apoptotic functions of E2F1 in a tumour microenvironment.
Swarnalatha M; Singh AK; Kumar V
J Cell Sci; 2013 Oct; 126(Pt 20):4636-46. PubMed ID: 23868976
[TBL] [Abstract][Full Text] [Related]
39. Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic properties.
Zent C; Kim N; Hiebert S; Zhang DE; Tenen DG; Rowley JD; Nucifora G
Curr Top Microbiol Immunol; 1996; 211():243-52. PubMed ID: 8585955
[TBL] [Abstract][Full Text] [Related]
40. Direct repression of the Mcl-1 promoter by E2F1.
Croxton R; Ma Y; Song L; Haura EB; Cress WD
Oncogene; 2002 Feb; 21(9):1359-69. PubMed ID: 11857079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
